Technological Advancements and Vaccine Development to Drive Revenue of Viral Antigens Market, States Fact.MR

As per the latest study by Fact.MR, a market research and competitive intelligence provider, the global viral antigens market is estimated at US$ 175.9 billion in 2022 and is expected to expand at a high CAGR of 8.2% from 2022 to 2032.

The entire world is facing health problems related to the rising outbreaks of various infectious & viral diseases, for which, viral antigens play a very crucial role. Investments in technology by government authorities as well as key market players support bringing in novel techniques to expand the production of antibodies in a host body.

For In-depth Analysis & Business Strategy, Buy a Copy of this Report –  

The introduction of viral antigens comes with several advantages such as ease of production & quality control, low level of toxicity, safe in case of oncogenic viruses, and feasibility if a virus cannot be cultivated. Thus, viral antigens are gaining the attention of researchers and clinicians, which is reflecting in the high market growth. In addition, advancements in image analysis software and informatics platforms for viral antigen detection are flourishing the development of vaccine research.

Fact.MR suggests that manufacturers need to invest in conducting clinical trials for further product improvisation. Key players need to introduce more immunogenic viral antigen vaccines than conventional inactivated whole-virus vaccines.

Key Takeaways from Market Study

  • The global viral antigens market is projected to expand at an impressive CAGR of 8.2% and be valued at US$ 388.1 billion by 2032.
  • The market expanded at 7.7% CAGR between 2017 and 2021.
  • Under detection technique, ELISA is estimated to be valued at US$ 55.5 billion in 2022.
  • North America dominated the global market with 49% share in 2021.
  • Sales of viral antigens are expected to increase at CAGRs of 8.4% and 9.8%, respectively, in North America and East Asia.

Development of numerous imaging modes is set to help researchers in capturing high-definition images and videos during viral antigen immunogenicity analysis,says a Fact.MR analyst.

For critical insights on this market, request for More Info – 

Market Development

Viral antigen suppliers are focusing on investing in research and development activities to amplify product development and gain a competitive edge in the market. Apart from that, mid-level and emerging players are competing with each other to gain fast approvals from government authorities to establish their products in the market.

Moreover, key players are investing in small start-ups and using diverse strategies such as mergers, acquisitions, partnerships, and joint ventures to maintain supremacy in the viral antigens market. The important aim behind this is to uphold a leading position in the market for viral antigens.

Segmentation of Viral Antigens Industry Research

  • By Component :

    • Influenza
    • Coronavirus
    • Zika
    • Ebola
    • Dengue
    • Herpes Simplex Virus (HSV)
    • Rotavirus
    • Epstein-Barr
    • Hepatitis A-E
    • Parainfluenza
    • Measles
    • Adenovirus
    • Mumps/Parotitis
    • Varicella Zoster Virus (VZV)
    • Others
  • By Detection Technique :

    • ELISA
    • Immunoassay
    • Hemagglutination
    • Radioimmunoassay (RIA)
    • Immunoperoxidase Staining
    • Immunofluorescence
    • Electron Microscopy
    • Others
  • By End User :

    • Hospitals
    • Clinics
    • Laboratories
    • Diagnostic Centers
    • Blood Banks
    • Research Institutes
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & ASEAN
    • Oceania
    • MEA

Choose Quick and Secure PayPal Payment Mode to Get Full Access of This Report –

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583